NCT07267871Completed
Oura Blood Pressure Profile Study
Oura Blood Pressure Profile Study: An Evaluation of the Oura Blood Pressure Profile Algorithm for Identifying Signs of Hypertension
Source: ClinicalTrials.gov · Last updated 21 Sept 2026
Brief summary (registry, in English)
The proposed study is designed as a prospective, single-arm, observational, non-significant risk device study to evaluate the performance of Oura's investigational Blood Pressure Profile algorithm in identifying signs of hypertension.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 382200 (actual)
- First submitted
- 14 Nov 2025
- Start date
- 17 Dec 2025
- Primary completion date
- 12 Aug 2026
- Lead sponsor
- Ouraring Inc.
- Diseases
- High blood pressure
- NCT number
- NCT07267871
What you commit to
- Study type: Observational
- Participants enrolled: 382200
- From 17 Dec 2025 to the primary completion date, 12 Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- User of implanted cardiac electronic device(s)
Other
- Currently pregnant
- Within 12 weeks postpartum
Who the study is looking for
- Located in United States
- Aged 22 years or older at time of eligibility screener
- Oura Ring user (Oura Ring Gen3 or newer)
- User of the English version of the Oura App
- Smartphone (iOS or Android) user
- Able to provide consent electronically
Age in the registry: 22 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ouraring Coordinator of this site? Confirm its status | San Francisco | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.